Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Baxter Healthcare Corporation recalls MYXREDLIN

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations
Products
  • MYXREDLIN
Where it was sold

US Nationwide; Puerto Rico; and Chile.

Nationwide

Units affected
N/A
About this recall
MYXREDLIN, Insulin Human in 0.9% Sodium Chloride Injection, 100 units/100 mL (1 unit/mL), Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0126-12.